Biologically Inspired Synthetic Enzymes Made from DNA  by Schlosser, Kenny & Li, Yingfu
Chemistry & Biology
ReviewBiologically Inspired Synthetic Enzymes
Made from DNA
Kenny Schlosser1 and Yingfu Li1,2,*
1Department of Biochemistry and Biomedical Sciences
2Department of Chemistry
McMaster University, Hamilton, ON L8N 3Z5, Canada
*Correspondence: liying@mcmaster.ca
DOI 10.1016/j.chembiol.2009.01.008
In cells, DNA typically consists of two antiparallel strands arranged in a double-helical structure, which is
central to its fundamental role in storing and transmitting genetic information. In laboratories, however,
DNA can be readily synthesized as a single-stranded polymer that can adopt many other types of structures,
including some that have been shown to catalyze chemical transformations. These catalytic DNA molecules
are commonly referred to as DNAzymes, or deoxyribozymes. Thus far, DNAzymes have not been found in
cells, but hundreds of structural and functional variations have been created in the laboratory. This alternative
catalytic platform has piqued the curiosity of many researchers, including those who seek to exploit them in
potential applications ranging from analytical tools to therapeutic agents. In this review, we explore the
unconventional role of DNA as a biologically inspired synthetic enzyme.Chemistry & Bioprotein. The absence of a 20-OH group at each phosphodiester
linkage makes DNA 100,000-fold more stable to hydrolysis
than RNA under physiological conditions (Li and Breaker,
1999a). DNA phosphodiester bonds are also 1000-fold more
resistant to hydrolytic degradation than are peptide bonds
(Smith and Hansen, 1998). Second, DNA is less expensive and
can be easily prepared through solid-phase synthesis. These
two preceding properties can generally make DNA more versa-
tile and convenient to use. Other practical characteristics of
DNA include the fact that it can be directly amplified by PCR
(whereas RNA must first be reverse transcribed), it can function
in solution and on surfaces via immobilization, and it can be
readily chemically modified to increase stability or provide extra
functional moieties. Therefore, DNAzymes can complement and
extend the type of applications that may be suitable for synthetic
enzymes. The various DNAzymes that have been reported to
date should also help to dispel any preconceived notions about
the functional limitations of DNA-based enzymes.
The Functional Repertoire of Synthetic DNA Enzymes
Enzyme active sites must precisely align catalytic and reacting
groups to lower the activation-energy barrier of a given reaction.
This requires a level of structural sophistication that the typical
double-stranded DNA helix would not be able to offer. Therefore,
it is important to recognize that single-stranded DNA can access
many more types of secondary and tertiary interactions, such as
nonstandard base pairs, hairpin loops, internal bulges, multistem
junctions, pseudoknots, and stacked guanine quadruplex
structures (Breaker, 1997). These additional interactions can
contribute to the formation of more intricate structures consis-
tent with the expectations of a catalytically active molecule.
The demonstration that a tRNA and its DNA analog can adopt
very similar structures was one of the early indications that
single-stranded DNA had the capacity to form complex struc-
tures (Paquette et al., 1990). Furthermore, the demonstration
that all but four positions within the hammerhead ribozyme couldIntroduction
Enzymes play an essential and pervasive role in biological
systems, because they can act as highly efficient and selective
catalysts under mild conditions. The general utility of natural
enzymes has inspired the development of new synthetic
versions (Jiang et al., 2008; Rothlisberger et al., 2008; Seelig
and Szostak, 2007), which may eventually provide access to
useful biotechnology, biomedicine, and industrial applications.
Although protein would be the most obvious choice of bioma-
terial from which to construct a synthetic enzyme, other types of
biopolymers have also been investigated for this purpose. With
fewer functional groups to assist in the formation of an active
site, nucleic acids may seem like a poor alternative, and yet nu-
cleic acid enzymes have a tangible and even fundamental pres-
ence in cells, as exemplified by the ribosome. This RNA-protein
complex is responsible for protein synthesis in all three domains
of life, and catalysis of the key peptidyl transfer step has been
attributed to large ribosomal RNA (Cech, 2000; Nissen et al.,
2000). Other naturally occurring ribozymes that catalyze the
cleavage or formation of RNA phosphoesters have also been
discovered (Doudna and Cech, 2002), and an even broader
range of chemical reactions can be catalyzed by synthetic ribo-
zymes (Silverman, 2009).
The concept of nucleic acid catalysis has been further vali-
dated by the demonstration that DNA also has the capacity for
catalytic function. DNAzymes have not been found in nature,
but they have been created in test tubes through a process
known as in vitro selection (Baum and Silverman, 2008). The
study of catalytic DNA can be rationalized from both an
academic and practical perspective. Finding the ‘‘lowest
common denominator’’ between different types of catalytic
biopolymers may provide a better understanding of the funda-
mental principles that govern enzymatic catalysis. Furthermore,
there are several notable advantages to using DNA over RNA or
protein, which could be leveraged toward the practical applica-
tion of DNAzymes. First, DNA ismore stable to use than RNA andlogy 16, March 27, 2009 ª2009 Elsevier Ltd All rights reserved 311
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Structures of the 8-17 and 10-23
RNA-Cleaving DNAzymes
The DNAzyme (blue) binds the RNA substrate (red)
throughWatson-Crick base pairing. For simplicity,
only nucleotides that comprise the catalytic core
of each DNAzyme are shown.
(A) 8-17. The catalytic core contains only four
(underlined) highly conserved nucleotides that
are required for robust activity. The original 8-17
sequence and cleavage site described by Santoro
and Joyce (1997) is illustrated, but faster sequence
variants with different cleavage site preferences
have been identified (Schlosser et al., 2008b).
(B) 10-23. The catalytic core consists of 15 nucle-
otides, of which most are highly conserved.312 Chemistry & Biology 16, March 27, 2009 ª2009 Elsevier Ltd All relsewhere (Achenbach et al., 2004; Baum and Silverman, 2008).
The majority of reactions listed above involve the processing or
modification of oligonucleotide substrates, primarily because
such reactions are more amenable to the in vitro selection
process by which DNAzymes are identified.
Rate enhancements vary by several orders of magnitude de-
pending on the type of reaction, but so far the upper limit that
has been observed is 1010-fold, for a DNAzyme that catalyzes
DNA adenylation (Li et al., 2000b). It should be noted that
although this represents the highest empirical value reported in
the literature, it remains plausible that higher rate enhancements
may still be achieved in the future.
Because of their significant applicative potential (as will be dis-
cussed later), RNA-cleaving DNAzymes have been the subject of
numerous studies (Silverman, 2005). One of the most thoroughly
investigated RNA-cleaving DNAzymes is a small metalloenzyme
known as ‘‘8-17’’ (Santoro and Joyce, 1997). Not unlike protein
enzymes, 8-17 can demonstrate good specificity at multiple
levels—first at the substrate-binding step, and then at the chem-
ical step of the transesterification reaction it catalyzes. As can be
seen in Figure 1, 8-17 engages a cognate nucleic acid substrate
by the formation of Watson-Crick base pairing upstream and
downstream of the target cleavage site. One advantage of this
type of interaction is that the sequence of the substrate-binding
arms can be modified to recognize any desired substrate
sequence, thereby providing a versatile mechanism for the tar-
geted cleavage of RNA. In contrast, protein ribonucleases
such as RNase T1 cleave indiscriminately at all locations con-
taining G residues. The 8-17 DNAzyme also has a specific
requirement for the identity of the two nucleotides flanking the
cleavage site. In this case, 8-17 catalyzes the cleavage of a
50-GG dinucleotide junction most effectively, whereas other
junctions can be cleaved with different levels of reduced activity
(Schlosser et al., 2008b). Finally, 8-17 shows regiospecificity by
cleaving native 30-50 phosphodiester linkages but not unnatural
20-50 linkages (Wang and Silverman, 2005a). Enantioselectivity
has also been demonstrated by other reported RNA-cleaving
DNAzymes (Ordoukhanian and Joyce, 2002).
The catalytic efficiency (kcat/KM) of 8-17 under simulated phys-
iological conditions (37C, 3 mMMg2+, and pH 7.4) has been re-
ported as 4 3 105 M1 min1 (Bonaccio et al., 2004). However,
studies conducted on another small RNA-cleaving DNAzyme
known as ‘‘10-23’’ (Figure 1) have revealed that it has a catalytic
efficiency of 3.2 3 108 M1 min1 under similar conditions,
and as high as 4.9 3 109 M1 min1 under elevated Mg2+be replaced with deoxyribonucleotides, without completely
abolishing activity, suggested that DNA could indeed participate
in the construction of catalytically competent structures (Per-
reault et al., 1990; Yang et al., 1992).
Any doubts about the catalytic ability of DNA were ultimately
resolved in 1994, when the first DNAzyme was reported (Breaker
and Joyce, 1994). This initial account described the isolation of
a 38 nt single-stranded DNA molecule, which catalyzed the
Pb2+-dependent cleavage of an RNA phosphoester embedded
within a separate DNA molecule. The cleavage reaction obeyed
Michaelis-Menten kinetics with a multiple turnover kcat value of
1 min1 at 23C and pH 7.0. The DNAzyme provided a rate
enhancement of 105-fold over the uncatalyzed reaction—
a modest achievement by protein enzyme standards, but never-
theless an important step forward in the emerging field of DNA
catalysis. Since then, many newDNAzymes have been reported,
which serve to demonstrate the functional versatility of this alter-
native catalytic platform. These DNAzymes can emulate some of
the same fundamental properties that are characteristics of
traditional protein enzymes, including high rate enhancements,
high specificity, and in some but not all cases, the ability to
perform multiple substrate turnovers.
DNAzymes that catalyze the cleavage of RNA are by far the
largest class of catalytic DNA molecules (Silverman, 2005),
although the list of DNA-catalyzed reactions also include RNA
ligation (including the formation of native 30-50 and nonnative
20-50 phosphodiester linkages) (Flynn-Charlebois et al., 2003a,
2003b; Purtha et al., 2005), RNA branching (Coppins and Silver-
man, 2005; Pratico et al., 2005;Wang and Silverman, 2003), RNA
lariat formation (Wang and Silverman, 2005b), DNA depurination
(Hobartner et al., 2007; Sheppard et al., 2000), oxidative DNA
cleavage (Carmi et al., 1996, 1998; Carmi and Breaker, 2001),
DNA ligation via 30 or 50 activation (Cuenoud and Szostak,
1995;Sreedhara et al., 2004),DNAbranching (Mui andSilverman,
2008), DNA coupling (i.e., formation of a phosphorothioester
linkage) (Levy and Ellington, 2001, 2002b), DNA phosphorylation
(Li and Breaker, 1999b; McManus and Li, 2007; Wang et al.,
2002), DNA adenylation (Li et al., 2000b), phosphoramidite
cleavage (Burmeister et al., 1997), porphyrin metallation (Li and
Sen, 1996), peroxidation (Travascio et al., 1998, 1999), thymine
dimer cleavage (Chinnapen and Sen, 2004), formation of nucleo-
peptide linkages (Pradeepkumar et al., 2008), and formation of
carbon-carbon bonds (i.e., through Diels-Alder cycloaddition)
(Chandra andSilverman, 2008). The variousDNAzyme-catalyzed
reactions established todatehavebeen reviewed ingreater detailights reserved
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corresponded very closely to the measured rates of enzyme-
substrate association (i.e., by the rate of DNA-RNA hybridization
in this case), suggesting that 10-23 can achieve near-catalytic
‘‘perfection,’’ consistent with the Albery and Knowles definition
as a situation in which the reaction rate is limited only by the
rate of diffusional encounter between enzyme and substrate
(Albery and Knowles, 1976).
The folding characteristics of 8-17 have also been examined in
some depth (Kim et al., 2007a, 2007b; Liu and Lu, 2002). These
studies have provided evidence indicating that catalysis in 8-17
can be activated by either an ‘‘induced-fit’’ or a ‘‘lock-and-key’’
mechanism, depending on the type of divalent metal ion used.
Thus, DNAzymes can exploit the same modes of activation
that RNA and protein metalloenzymes use, providing further
evidence of the fundamental similarities between all three cata-
lytic platforms. If DNAzymes can use the same modus operandi
as protein enzymes, it seems reasonable to suggest there may
be fewer intrinsic limitations to proficient DNA catalysis than
generally perceived.
Catalytic Strategies Employed by DNAzymes
DNA lacks the type of functional groups found on amino acid
side chains that aremost commonly recognized as catalytic resi-
dues, including the imidazole of His, the carboxylate of Asp and
Glu, the alkyl amine of Lys, and the sulfhydryl of Cys. Further-
more, at neutral pH, the nucleobases of DNA do not have signif-
icant acid/base properties. Despite these apparent limitations,
DNA has shown a remarkable aptitude for catalysis as described
in the preceding section. Therefore, the basic principles that
govern protein catalysis are likely to be applicable to nucleic
acid catalysis as well, although the chemical differences
between polypeptides and polynucleotides could make some
catalytic strategies more accessible to one biopolymer over
the other.
Most DNAzymes require one or more divalent metal ions for
activity. DNA is likely predisposed to utilize this type of catalytic
strategy because there are many potential binding/coordination
sites for positively charged metal ions along the negatively
charged phosphate backbone, as well as the N and O atoms
of the nucleobases. Divalent metal ions can facilitate the folding
of DNA into higher-order structures, and/or could potentially act
as Lewis acids and general bases (in the form of a metal
hydroxide) that contribute directly to chemical catalysis by stabi-
lizing the attacking and/or leaving groups (Narlikar and Hers-
chlag, 1997). It should be noted that in most cases the precise
role of the obligate metal cofactor, structural and/or catalytic,
has not been elucidated.
Other types of cofactors have also been used productively by
DNAzymes. An RNA-cleaving DNAzyme was identified that
utilized the amino acid histidine as a cofactor, for which the imid-
azole group was suggested to act as a general base (Roth and
Breaker, 1998). A DNAzyme that catalyzes site-selective depuri-
nation with the aid of periodate (as an apparent oxidizing agent)
has also been reported (Hobartner et al., 2007).
DNAzymes that can function in the absence of divalent metal
cofactors have also beendeveloped (Geyer andSen, 1997, 2000).
In one report, an RNA-cleaving DNAzyme that only required
monovalent ions exhibited a rate enhancement of 108-foldChemistry & Bioover the uncatalyzed reaction (Geyer andSen, 1997). The authors
speculated that the DNAzyme may use one or more of the
following catalytic strategies: general acid or base catalysis,
precise positioning of reactive groups, and/or stabilization of
the transition state. It should be noted that acid/base catalysis
has never been explicitly demonstrated in DNAzymes. However,
it is conceivable that the folded structure of a DNAzyme could
create a microenvironment in which the pKa of relevant nucleo-
bases are perturbed to near-neutrality, thereby making them
more suitable for acid/base catalysis. This scenario has been
implicated in the mechanisms of various nucleolytic ribozymes
(Bevilacqua and Yajima, 2006).
The DNAzyme field can still be considered to be in its formative
years, as much of the finer mechanistic details have yet to be
elucidated, or even adequately addressed. For instance, high-
resolution structural data for any DNAzyme (in a productive
conformation) have not been reported, although some apparent
effort has been made toward this end (Nowakowski et al., 1999).
Therefore, this aspect of the DNAzyme field should represent
a priority for future research. In the meantime, it may be instruc-
tive to review the mechanisms employed by natural ribozymes
(Cochrane and Strobel, 2008), which have been far more thor-
oughly investigated, and should provide relevant insight into
the possible catalytic strategies employed by DNAzymes.
Functional Limitations of DNA-Mediated Catalysis:
Can DNAzymes Compete with Ribozymes
and Protein Enzymes?
The large variety of deoxyribozymes that have emerged over the
last 15 years has lent credence to the concept of a DNA enzyme,
yet there is still an underlying question as to the fundamental
limits of DNAzyme-mediated catalysis. Does DNA have the
capacity to match the catalytic proficiency observed with ribo-
zymes or even protein enzymes? The fewer functional groups
in DNA could arguably constrain the structural versatility of DNA-
zymes, and impose an intrinsic (albeit undefined) limit on the
magnitude of any catalytic function relative to RNA or protein.
However, there is growing empirical evidence to suggest that
the functional disparity between DNAzymes and more traditional
biocatalysts may actually be quite small (at least in some cases).
The absence of a 20-hydroxyl group in DNA (which removes
a potential hydrogen-bond donor/acceptor) does not appear to
have significant functional consequences for deoxyribozymes
relative to ribozymes. The rate enhancements between various
types of DNAzymes and their synthetic ribozyme counterparts
are generally comparable (Baum and Silverman, 2008). DNA-
zymes (Santoro and Joyce, 1997) and synthetic ribozymes
(Tang and Breaker, 2000) that cleave RNA are a good example.
Analogous rate enhancements have also been observed when
direct comparisons have been experimentally attempted, as is
the case with two different DNAzymes that were derived from
the sequence of existing ribozymes that catalyze carbon-carbon
bond formation (Chandra and Silverman, 2008) and RNA ligation
(Paul et al., 2006).
In comparing the relative catalytic abilities of DNA and RNA, it
may also be instructive to consider the minimum requirements
under which each class of polymer can sustain activity. Ribo-
zymes and deoxyribozymes have shown a similar level of toler-
ance for the use of simpler nucleotide alphabets which lacklogy 16, March 27, 2009 ª2009 Elsevier Ltd All rights reserved 313
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RNA ligase ribozyme was first evolved to function in the absence
of cytidine (Rogers and Joyce, 1999), and subsequently in the
absence of both cytidine and guanosine (Reader and Joyce,
2002). The resulting ribozyme was 20,000-fold less active
than the original parent molecule from which it was derived
(containing all four types of ribonucleotides), but still 36,000-
fold faster than the uncatalyzed reaction. Similarly, an RNA-
cleaving DNAzyme with a simplified catalytic core composed
of just guanosine and cytidine nucleotides has also recently
been reported (Schlosser and Li, 2009). This DNAzyme was
10,000-fold less active than the parent DNAzyme from which
it was derived (containing all four types of nucleotides), but
still 5,300-fold faster than the uncatalyzed reaction. Collec-
tively, these empirical examples suggest that DNA can exhibit
the same structural and functional plasticity as RNA, and indicate
that differences in their base identity and backbone composition
do not represent a significant functional limitation for one or
the other.
The differences between DNA and protein are far more exten-
sive, and expected to create a larger functional gap between
them. Nevertheless, there are theories that challenge this
perception, and even some experimental evidence that suggests
the functional gap may not be insurmountable. A conceptual
framework has been proposed to understand the current ‘‘speed
limit’’ (i.e., a rate constant of 2 min1) that is commonly
observed among synthetic RNA-cleaving ribozymes and deoxy-
ribozymes (Breaker et al., 2003). The authors of this study inves-
tigated the kinetic characteristics of a variety of synthetic ribo-
zymes and deoxyribozymes, and concluded that they use only
some combination of two of the four possible catalytic strategies
that could accelerate this reaction. It follows that nucleic acid
enzymes that can optimally exploit three or more strategies
could potentially achieve protein-like rate enhancements.
Consistent with this theory, some natural RNA-cleaving ribo-
zymes can exceed the aforementioned speed limit by two to
three orders of magnitude (Canny et al., 2004; Roychowdhury-
Saha and Burke, 2006; Zamel et al., 2004) and approach
the 80,000 min1 rate constant exhibited by the protein
enzyme RNase A (del Cardayre and Raines, 1994). Presumably,
the higher degree of structural complexity in these natural ribo-
zymes (including the use of structural elements peripheral to
the putative catalytic core) (Khvorova et al., 2003) can allow
them to use extra catalytic strategies, and/or to use them more
optimally as compared to their synthetic counterparts.
Although analogous rate constants for RNA-cleaving DNA-
zymes have yet to be experimentally demonstrated, there are
other examples where the catalytic properties of DNAzymes
have compared favorably with their protein counterparts. For
instance, a porphyrin metallating deoxyribozyme exhibits a kcat
of 3.8 3 103 s1 (Li and Sen, 1996), which is slightly higher
than the kcat of 2.4 3 10
3 s1 exhibited by a corresponding
catalytic antibody for the same reaction (Cochran and Schultz,
1990). The 10-23 deoxyribozyme cleaves RNA with a kcat/KM
of109M1min1 under optimal conditions (Santoro and Joyce,
1997, 1998), which is 10-fold higher than the analogous value
for RNase A (del Cardayre and Raines, 1994). Of course, these
select examples are not representative of the majority of
DNAzymes identified to date, but they do raise a valid question:314 Chemistry & Biology 16, March 27, 2009 ª2009 Elsevier Ltd Allis the true catalytic power of DNAzymes limited by chemistry, or
just by discovery? Whereas natural protein enzymes have had
the benefit of billions of years of evolution to refine their catalytic
abilities, all DNAzymes have been created through test-tube
evolution experiments, which are typically conducted on a time-
scale measured in weeks or even days.
Searching Sequence Space through In Vitro Selection
The development of in vitro selection in 1990 (also referred to as
SELEX when used to isolate molecular recognition elements
called aptamers) (Ellington and Szostak, 1990; Robertson and
Joyce, 1990; Tuerk and Gold, 1990) provided a powerful new
approach to directly explore the catalytic abilities of nucleic
acid enzymes, by creating synthetic versions in a laboratory. In
vitro selection is currently the only way by which DNAzymes
can be created, as it is not yet practical to rationally design
them from first principles.
Every in vitro selection experiment begins with the basic
presumption that DNAzymes are present in random sequence
space, and simply need to be found. The primary benefit of
in vitro selection is that it can identify DNAzymes from hundreds
of trillionsof randomsequences,without systematically screening
every sequence for activity. The challenge is to devise a selection
strategy that caneffectively discriminatebetween thecatalytically
active versus inactive molecules that are typically in excess by
many orders of magnitude.
An initial combinatorial library composed of 1014 different
DNA sequences (generated by solid-phase chemical synthesis
using appropriate DNA phosphoramidate mixtures) has tradi-
tionally provided sufficient diversity to satisfy the requirement
that at least one sequence (and often more) can adopt a func-
tional structure. In order to distinguish between active and
inactive molecules, the reaction they catalyze must result in
some form of self-modification (e.g., a change in size or change
in the ability to bind an immobilized reagent) that allows the
active molecules to become ‘‘selectable.’’ For instance, an
RNA-cleaving deoxyribozyme can cleave a covalently linked
RNA substrate and therefore become shorter in length. These
active molecules can then be separated from the longer un-
cleaved (inactive) molecules by virtue of their increased mobility
during gel electrophoresis (although this may seem to contradict
the notion that a true catalyst accelerates the rate of a reaction
without itself being consumed; in practice, it is usually possible
to convert a self-modifying deoxyribozyme into a true catalyst,
simply by separating the substrate and enzyme into distinct
functional domains). The selected DNA molecules then serve
as templates for amplification by the polymerase chain reaction
(PCR). PCR amplification is possible because the DNA
sequences in the original library are designed with primer-
binding sites. Mutagenic PCR (Cadwell and Joyce, 1994) is
sometimes used to intentionally introduce random mutations
into the sequence population, in an effort to cover more
sequence space.
Prior to the next round of selection, the double-stranded PCR
product must be separated into individual strands so that the
DNAzyme-coding strand is free to fold into its catalytically active
structure. A variety of mechanisms can be used to this effect, as
described elsewhere (Silverman, 2005). The overall process of
in vitro selection constitutes a cycle that typically must berights reserved
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ciently represented to enable their identification by molecular
cloning and sequencing. Depending on the specific number
and type of steps involved in a given selection scheme, one
round of selection can potentially be completed in a single day,
and anywhere from 5 to 15 rounds of selection may be required
in total. Multiple rounds of in vitro selection are always required,
because some fraction of inactive ‘‘background’’ sequences will
have a finite probability of surviving each round of selection
simply by chance.
In essence, DNAzyme engineers design selection schemes to
partition the catalytically activemolecules away from the inactive
molecules, and with each round of selective amplification, the
ratio of active to inactive molecules in the pool is effectively
increased. Ultimately, by progressively increasing the selection
stringencyover successive rounds (e.g., bydecreasing the selec-
tion time or cofactor concentration), the many trillions of random
sequences in the original library will be narrowed down to one or
more sequences that can best meet the selection criteria
(Figure 2). Amore comprehensive description of the in vitro selec-
tion process has been provided elsewhere (Silverman, 2008).
Recognizing the Limits of In Vitro Selection
and the Implications for Mapping the Functional
Limits of DNAzymes
Sequence space can be defined as all the sequence permuta-
tions (or some subset) associated with an oligonucleotide of
N random nucleotides. Because DNA is composed of only four
different nucleotides, the total sequence space represented
by a DNA molecule composed of N random nucleotides is 4N
sequences. There exists an enormous disparity between the
amount of sequence space that is theoretically accessible (e.g.,
1030 different sequences for N = 50) versus the amount that
can be practically searched in a single experiment (i.e., 1014
molecules). To put these numbers in more physical terms, it
would take more than 30,000 tons of DNA to screen all possible
sequence permutations represented by just 50 random nucleo-
tides. In contrast, in vitro selection experiments are limited to
microgram quantities of DNA, and therefore can only sample
a minuscule fraction of the total available sequence space.
If sequence space cannot be explored exhaustively, mapping
the limits of DNAzyme function will ultimately depend on how
effectively it can be explored. Toward this end, efforts to under-
stand how the outcome of in vitro selection can be influenced
by different experimental parameters such as the reaction time
(Schlosser and Li, 2004), type of divalent metal cofactors
(Wang et al., 2002), length of the random sequence domain (Ge-
vertz et al., 2005; Sabeti et al., 1997), excess sequence elements
(Schlosser et al., 2006), and population dynamics (Schlosser and
Li, 2005) will continue to be a constructive pursuit. These studies
can provide insight on how best to access new functional motifs,
and avoid the recurrence of existing catalytic molecules such as
8-17, for which variants have been isolated on at least six sepa-
rate occasions (Cruz et al., 2004; Faulhammer and Famulok,
1996; Li et al., 2000a; Peracchi, 2000; Santoro and Joyce,
1997; Schlosser et al., 2008a; Schlosser and Li, 2004).
Along the same lines, the development of techniques that can
remove some of the constraints associated with standard in vitro
selection strategies will be highly useful. In vitro selection exper-Chemistry & Biments that incorporate automation (Eulberg et al., 2005), recom-
bination (Bittker et al., 2002), continuous evolution (Johns and
Joyce, 2005), and/or multiple turnover (e.g., through in vitro
compartmentalization) (Levy et al., 2005) selection formats
have provided new ways to facilitate sequence space explora-
tion for ribozymes and aptamers. These techniques may not
be immediately applicable to DNAzymes, but they represent
the kind of innovations that could potentially be developed to
benefit the DNAzyme field as well.
DNAzymes for Diverse Applications In Vitro and In Vivo
Aside from the inherent academic interest in DNAzyme-medi-
ated catalysis, research in this field is also motivated by the
potential practical applications. These applications can be
broadly classified into several categories including molecular
biology tools, therapeutic agents, nanomotors, analytical tools,
and computational devices. Table 1 provides some perspective
on the breadth of applications in which DNAzymes have partici-
pated. Some of these applications are of immediate practical
utility (such as the use of RNA-cleaving DNAzymes as in vitro
endoribonucleases), whereas others have been validated in
proof-of-principle studies, but must still overcome additional
obstacles before they can be used productively (such as DNA
computational devices). Themajority of these applications utilize
8-17 and 10-23 described earlier (Figure 1), because they
possess several practical characteristics including (1) small size
(i.e., 30 nt), (2) relatively high activity and multiple turnover
abilities (i.e., 1 min1, but can be faster or slower depending
on buffer conditions), (3) the ability to cleave both all-RNA and
chimeric substrates (i.e., DNA oligonucleotides containing an
embedded ribonucleotide), (4) the ability to function with
Figure 2. Conceptual Diagram of In Vitro Selection
In vitro selection begins with a combinatorial DNA library typically composed
of 1014 different sequences. Individual molecules are selected for a desired
activity, and the active molecules are partitioned away from the inactive mole-
cules, usually through polyacrylamide gel electrophoresis (PAGE) or some
form of affinity chromatography. The active molecules are then amplified by
the polymerase chain reaction (PCR). The resulting double-stranded DNA
molecules are converted into single-stranded DNA molecules (i.e., by removal
of the noncoding antisense strand), and then used to initiate the next round of
selective amplification.iology 16, March 27, 2009 ª2009 Elsevier Ltd All rights reserved 315
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Primary Category Secondary Category Examples Selective References
Molecular biology tools Practical RNA cleavage Pyle et al., 2000
Practical RNA ligation 30-50 linkages Purtha et al., 2005
Lariat RNA Wang and Silverman, 2005b
Branched RNA Pratico and Silverman, 2007; Pratico et al., 2005;
Wang and Silverman, 2006
RNA labeling Baum and Silverman, 2007
Therapeutic agents:
mRNA cleavage in vivo
Antiviral Influenza A Takahashi et al., 2004
Hepatitis C core protein Trepanier et al., 2006
HIV-1 Chakraborti and Banerjea, 2003
Antibacterial b-lactamase Hou et al., 2007b
penicillin-binding protein Hou et al., 2007a
Anticancer VEGFR2 Zhang et al., 2002
c-Jun Fahmy et al., 2006; Zhang et al., 2004
Egr-1 Bhindi et al., 2006; Mitchell et al., 2004;
Santiago et al., 1999
Nanomotors: mechanical motion Opening/closing Chen and Mao, 2004; Chen et al., 2004
Walking Tian et al., 2005
Analytical tools:
Detection and/or quantitation
Proteins Streptavidin Stojanovic et al., 2000
Lysozyme Li et al., 2007
Nucleic acids DNA and/or RNA Sando et al., 2003; Tian and Mao, 2005;
Todd et al., 2000
RNA Suenaga et al., 2005
Sequence polymorphisms Cairns et al., 2000; Cairns and Sun, 2004
RNA modifications 20-O-methylribose Buchhaupt et al., 2007
pseudouridines Buchhaupt et al., 2007; Hengesbach et al., 2008
m5C Hengesbach et al., 2008
Small molecules Adenosine Liu and Lu, 2004a
AMP Li et al., 2007
ATP Cho et al., 2005; Levy and Ellington, 2002a;
Mei et al., 2003
Metal ions Pb2+ Chang et al., 2005; Li and Lu, 2000;
Liu and Lu, 2003a; Xiao et al., 2007
UO2
2+ Liu et al., 2007
Cu2+ Liu and Lu, 2007a, 2007b
Hg2+ Hollenstein et al., 2008; Liu and Lu, 2007c
Computational devices Boolean function logic gates Chen et al., 2006; Stojanovic et al., 2002, 2005
Arithmetic operations Half-adder Stojanovic and Stefanovic, 2003a
Full adder Lederman et al., 2006
Automata Circuits that play
tic-tac-toe
Macdonald et al., 2006;
Stojanovic and Stefanovic, 2003b
A representative overview of the various types of applications in which DNAzymes have been employed. Some applications are of immediate practical
utility, whereas others may represent proof-of-principle demonstrations of potential utility. The majority of these applications exploit the 8-17 and
10-23 RNA-cleaving DNAzymes (or sequence variations thereof).316 Chemistry & Biology 16, March 27, 2009 ª2009 Elsevier Ltd All rDNAzymes; however, we will briefly highlight a few applications
of particular significance or interest.
The in vitro manipulation of RNA represents the most
obvious and straightforward application of DNAzymes that
catalyze RNA cleavage (Silverman, 2005). DNAzyme-based en-
doribonucleases can offer an immediate practical alternative todifferent divalent metal cofactors, and (5) versatile substrate
recognition abilities (i.e., substrate recognition arms that can
be modified to match virtually any target sequence). These char-
acteristics have contributed to their widespread and convenient
integration into different types of applications. It is beyond the
scope of this review to address the full applicative potential ofights reserved
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RNase H (Lapham and Crothers, 1996) techniques for the
preparation of homogeneous RNA transcripts, and for the
general processing activities involved in RNA structural studies
(Pyle et al., 2000). The utility of RNA-cleaving DNAzymes can
also be extended to in vivo applications. In this respect, they
have been investigated as tools to dissect the biological func-
tion and/or to downregulate the expression of genes associ-
ated with disease. A growing number of studies have demon-
strated the potential for these DNAzymes to selectively
attenuate the expression of various antibacterial (Hou et al.,
2007a, 2007b), antiviral (Chakraborti and Banerjea, 2003; Taka-
hashi et al., 2004; Trepanier et al., 2006), and anticancer
targets (Fahmy et al., 2003; Khachigian et al., 2002; Mitchell
et al., 2004; Zhang et al., 2002, 2004). Their efficacy has
been evaluated in cell-culture assays as well as in several rele-
vant animal models of cancer, in which tumor sizes were
reduced by 60%–90% (Fahmy et al., 2003; Khachigian et al.,
2002; Mitchell et al., 2004; Zhang et al., 2002, 2004). For a
more comprehensive description of the various therapeutic
targets of DNAzymes, readers are encouraged to consult any
one of several good reviews (Bhindi et al., 2007; Dass et al.,
2008; Peracchi, 2004).
10-23 has been the most common choice for in vivo applica-
tions of RNA-cleaving DNAzymes, largely because it was the first
DNAzyme to be thoroughly characterized, and shown to sustain
a relatively useful level of activity under the low Mg2+ concentra-
tions found in cells. Unfortunately, 10-23 has a specific require-
ment for a 50-purine-pyrimidine dinucleotide cleavage site, which
can impose some restrictions on its utility. Therefore, the identifi-
Figure 3. ADNANanomotor Based on 10-23
The DNA motor is composed of two oligonucleo-
tide strands. One strand (blue) contains 10-23,
and the other strand (cyan) contains a donor-
acceptor pair of fluorophores, F1 and F2, on
opposing ends. The presence of the two fluoro-
phores allows any change in motion to be
observed through fluorescence resonance energy
transfer (FRET). The motor is fueled by a chimeric
(DNA/RNA) oligonucleotide substrate (red), which
is susceptible to cleavage by 10-23. In the
absence of the substrate, the motor adopts
a ‘‘closed’’ conformation, characterized by a low
fluorescence signal. However, when the substrate
hybridizes to the DNAzyme, the DNA motor
adopts an ‘‘open’’ conformation that leads to an
increased fluorescence signal. Cleavage and
subsequent dissociation of the substrate allows
the DNA motor to once again adopt the closed
conformation. This motor continues to cycle
between the open and closed states as long as
substrate is available.
cation of new DNAzymes that can sepa-
rately, or in combination, enable the effi-
cient cleavage of all 16 possible RNA
dinucleotide junctions under physiolog-
ical conditions represents an important
ongoing challenge. Thus far, it has proven
difficult to satisfy all of these require-
ments. For instance, a combination of
in vitro selection andmutagenesis studies
has led to the identification of different 8-17 sequence variations
(Cruz et al., 2004; Schlosser et al., 2008b) and completely new
DNAzymes (Schlosser et al., 2008a) that collectively cleave all
16 dinucleotide junctions with a minimum rate constant of
0.1 min1. However, efficient cleavage was generally only
observed in the presence of Mn2+, and against chimeric
substrates (which are often used because they can provide a
specific cleavage site during in vitro selection). Although
improvements to the activity and cleavage site versatility of
RNA-cleaving DNAzymes are expected to facilitate their use and
efficacy in vivo, there are additional factors that may ultimately
limit their utility. As with other nucleic acid-based therapeutic
strategies such as antisense, ribozyme, and siRNA, the practical
implementation of DNAzymes can be complicated by issues
related to delivery, intracellular stability, cellular distribution,
and off-target effects. For a discussion of the relative merits of
these competing strategies, the reader is referred elsewhere
(Baum and Silverman, 2008; Bhindi et al., 2007; Peracchi, 2004).
DNAzymes have also been incorporated into more avant-
garde applications that attempt to mimic aspects of biological
systems. For instance, DNAzymes have been used to power
autonomous DNA nanomotors that can perform continuous
conformational changes without human interference (Figure 3).
Not unlike cellular protein motors that employ an ATPase to
extract chemical energy from ATP, these DNA nanomotors use
an RNA-cleaving DNAzyme to extract the chemical energy
stored in RNA phosphodiester bonds. This chemical energy is
subsequently converted into mechanical motions that imitate
the opening and closing action of scissors (Chen and Mao,
2004; Chen et al., 2004), or even walking (Tian et al., 2005).Chemistry & Biology 16, March 27, 2009 ª2009 Elsevier Ltd All rights reserved 317
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The 50 end of the substrate and the 30 end of 8-17
are labeled with a fluorophore (F) and quencher
(Q), respectively. The DNAzyme (blue) binds to
the substrate (red) through conventional Watson-
Crick base pairing (vertical lines), which positions
the quencher close to the fluorophore to limit fluo-
rescence emission. In the presence of Pb2+ ions,
the DNAzyme becomes active and cleaves the
single ribonucleotide linkage (rA, adenosine ribo-
nucleotide) embedded in an otherwise all-DNA
oligonucleotide. The individual cleavage frag-
ments have lower affinity for the DNAzyme, and
therefore dissociate to yield a concomitant
increase in fluorescence intensity as the fluoro-
phore moves away from the quencher.318 Chemistry & Biology 16, March 27, 2009 ª2009 Elsevier Ltd All rcommunication module and DNAzyme, with a concomitant
increase in the catalytic activity. Allosteric DNAzymes based
on this modular design philosophy can provide a versatile plat-
form for broad target recognition in diagnostic applications.
The amenability of DNAzymes to rationally designed allosteric
control has also been exploited to create molecular-scale
computational elements. For instance, allosteric RNA-cleaving
DNAzymes that respond to the presence and/or absence of
one or more oligonucleotide effectors with the production of
a signal have been engineered into logic gates that can execute
Boolean functions such as ‘‘AND,’’ ‘‘NOT,’’ and ‘‘XOR’’ (Stoja-
novic et al., 2002). The potential intricacy of control that can be
exerted by DNAzyme-based logic gates has been demonstrated
through the development of higher-order systems that employ
networks of parallel logic gates to perform arithmetic operations
(Lederman et al., 2006; Stojanovic and Stefanovic, 2003a), or
even function as automata to play games such as tic-tac-toe
(Macdonald et al., 2006; Stojanovic and Stefanovic, 2003b).
In addition, logic gates constructed from different types of
DNAzymes have been constructed to increase their versatility.
For instance, DNAzymes that catalyze DNA ligation were used
to generate larger output molecules that could subsequently
serve as input molecules for downstream gates (Stojanovic
et al., 2005), thereby demonstrating the potential for signal trans-
duction cascades, by utilizing a combination of both parallel and
serial circuits. Of course, these DNA-based computational
devices are not expected to compete with silicon-based
computers. Instead, because of their biocompatibility, DNAzyme
logic gates have been envisaged as a cellular platform from
which to control autonomous therapeutic and/or diagnostic
devices (Stojanovic et al., 2002). For example, DNAzyme logic
gates could potentially analyze the presence of molecular
disease markers and make appropriate decisions to trigger the
release of a drug.
Conclusions
Synthetic DNAmolecules have the capacity to catalyze chemical
transformations with high activity and selectivity, and therefore
can potentially offer a practical alternative to more traditional
biocatalysts. The use of these DNAzymes, alongside RNA and
protein enzymes, will no doubt enrich the scale and complexity
to which researchers will be able to probe and manipulate the
function of biological systems in the future. In the meantime,
DNAzymes are currently more suitable for applications in vitro,Various analytical devices have also been developed from
DNAzymes, in order to detect nucleic acids, metal ions, and
small organic molecules. One of the first DNAzyme biosensors
was based on 8-17, and exploited its Pb2+-dependent RNA
cleavage activity (Figure 4) (Li and Lu, 2000). A Pb2+ biosensor
was constructed with a fluorescent reporting system, by simply
labeling the 50 end of the substrate oligonucleotide with a fluoro-
phore, and the 30 end of the DNAzyme strandwith a fluorescence
quencher. In the uncleaved state, the substrate binds to the
DNAzyme, positioning the fluorophore and quencher in proximity
to each other for maximal fluorescence quenching. When Pb2+ is
introduced into the solution, the DNAzyme becomes active and
cleaves the substrate, which subsequently dissociates from the
DNAzyme to generate a fluorescence signal. The signaling prop-
erties of this original design have been improved by modifying
the number, arrangement, and type of fluorophores and
quenchers used (Chiuman and Li, 2007; Liu and Lu, 2003b).
Alternative reporter systems have also been developed based
on colorimetric (Liu and Lu, 2003a, 2004b) and electrochemical
detection methods (Xiao et al., 2007). Biosensors for other types
of toxic metal ions including Cu2+ (Liu and Lu, 2007a, 2007b),
Hg2+ (Hollenstein et al., 2008; Liu and Lu, 2007c), and UO2
2+
(Liu et al., 2007) have been developed as well. These biosensors
can offer exquisite sensitivity and selectivity, as reflected by the
UO2
2+ sensor that exhibits parts per trillion sensitivity and
million-fold selectivity (Liu et al., 2007).
The utility of DNAzyme biosensors can be further expanded by
creating allosterically regulated versions. Although the concept
of allosteric control in nucleic acid enzymes has been explored
more extensively for ribozymes (Breaker, 2002), representative
examples of allosteric deoxyribozymes that respond to small
molecules such as adenosine and ATP have also been reported
(Cho et al., 2005; Levy and Ellington, 2002a; Liu and Lu, 2004a;
Mei et al., 2003; Shen et al., 2006). Allosteric DNAzymes incorpo-
rate an aptamer domain, which provides additional molecular
recognition abilities. Aptamers are single-stranded DNA (or
RNA) molecules that can bind with high affinity and specificity
to many different types of molecules including metal ions, small
organic compounds, metabolites, and proteins (Famulok et al.,
2000). The activity of an allosteric DNA enzyme is regulated by
the ligand-binding state of the aptamer, through a ‘‘communica-
tion module’’ (Breaker, 2002) that is typically a weakened stem
structure. Ligand binding causes a conformational change in
the aptamer domain that leads to stabilization of both theights reserved
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Reviewbut their precise roles will likely be redefined as new and
improved versions are identified.
Understanding what the true scope of DNA’s catalytic abilities
may entail is an intriguing question. However, a clear answermay
never be found, because only small fractions of sequence space
are actually subject to scrutiny. Nevertheless, every new in vitro
selection experiment can provide additional clues to the global
distribution of function in sequence space, and mapping the
functional limits of DNA catalysis will depend, to a large extent,
on how frequently and effectively this technique is employed.
Of course, there are limits to what DNAzyme engineers alone
can achieve. Significant progress in the DNAzyme field, and
the productive use of its related applications, will ultimately be
coupled to the development of complementary technologies in
various other fields, including those at the interface of chemistry
and biology.
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